Preview
Description
A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination with Standard of Care Immunotherapy in Participants with Resected or Unresectable KRAS G12C-Mutant, Non-Small Cell Lung Cancer - SUNRAY-02. This app is specifically intended for participants in the J3M-MC-JZQH study only.
What's New
Version 5.4.1100 2025-11-20
This update includes improvements and bug fixes to enhance your experience. Technical Analysis
Package Overview Basic metadata
Bundle ID
com.medable.lilly-jzqh.patient Current Version 5.4.1100
Minimum iOS 14.0
Package Size App Store Size
Package Metadata 1 / 2 version records
Detailed binary, privacy manifest, framework, and Info.plist results have not been indexed for this package yet. The verified App Store and archive metadata above remains available.
Developer Information
Known Version Records
1 version record with stored package metadata • 2 known version records
Stored metadata does not guarantee a package is currently available to download.
| Details | Version / IDs | Version date | Action |
|---|---|---|---|
| 100.24 MB | v5.4.1100 App Store ID: 875692033Build: 5.4.1100 | 2025-11-20 23:15:06 | Get Version |
| Not archived | App Store ID: 866083259 | Unknown | Request Version |